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Summary 
 
Our objective was to determine whether 
delaying the PGF2α injection by 24 or 48 hr 
after the first GnRH injection in an Ovsynch 
protocol (from a standard 7 days) altered ovar-
ian characteristics in lactating dairy cows. Es-
trous cycles were synchronized in 36 Hol-
steins after removal of a progesterone-
releasing controlled internal drug release 
(CIDR) insert and injection of PGF2α. On day 
6 of the estrous cycle, cows were administered 
100 μg of GnRH (81 ± 2 days postpartum) and 
assigned randomly to receive a treatment in-
jection of PGF2α 7, 8, or 9 days later. Timed 
artificial insemination (TAI) was performed at 
48 hr after PGF2α, at which time a second in-
jection of GnRH was administered. Ovarian 
structures were mapped by ultrasonography on 
day 0 (first GnRH injection), on day 2 to de-
termine responses to the first GnRH injection, 
at PGF2α injection, and daily thereafter 
through 72 hr after PGF2α to monitor ovula-
tion of preovulatory follicles. Blood was col-
lected on day 0, day 2, at PGF2α injection, and 
at 24 and 48 hr after PGF2α, to monitor serum 
changes estradiol-17ß and progesterone. On 
the basis of serum progesterone and ovarian 
exams, 2 cows were eliminated because of 
anestrus and their failure ovulate a follicle in 
response to the first GnRH injection. Two 
other cows in which luteolysis failed to occur 
after PGF2α treatment also were eliminated. 
Final numbers of cows per treatment were: 7 
days (n = 13), 8 days (n = 9), and 9 days (n = 
10). Twenty-nine of 32 cows ovulated 
(90.6%) in response to the first GnRH injec-
tion. Despite a 24- or 48-hr delay between first 
GnRH and PGF2α injections, the diameter 
(mm) and volume (mm3) of the ovulatory fol-
licle did not differ among treatments. In all 32 
cows, at least 1 follicle ovulated after treat-
ment, but ovulation rates did not differ. Serum 
concentrations of estradiol-17ß did not differ 
among treatments. Two cows in the 7-day 
treatment and 2 cows in the 8-day treatment 
were inseminated 24 hr late and were ex-
cluded before assessing conception rates: 5/9 
(55.6%), 5/9 (55.6%), and 1/10 (10%), respec-
tively. We concluded that delaying PGF2α in-
jection by 24 hr had little effect on outcomes. 
 
(Key Words:  Follicle, Ovsynch, Ovulation, 
Pregnancy Rate.) 
 
Introduction 
 
 Before advent of the Ovsynch protocol 
[injection of GnRH 7 days before and 48 hr 
after an injection of PGF2α, with one timed AI 
(TAI) at 12 to 16 hr after the second GnRH 
injection], 33% of all dairy operations were 
using some type of programmed breeding sys-
tem that used prostaglandin F2α (PGF2α) to 
synchronize estrus, with rates of use greater 
for operations with 200 or more cows (50.2%) 
than for those with 100 to 199 cows (45%) or 
less than 100 cows (31.1%). Since then, timed 
AI (TAI) protocols likely have become even 
more popular among dairy producers, and are 
used in nearly 10% of all U.S. dairy herds. 
 
 Development of synchronized ovulation 
was based on earlier reports in which a new 
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follicular wave was initiated in response to an 
injection of GnRH 6 to 7 days before PGF2α 
injection.  Emergence of a new follicular wave 
in response to GnRH led to greater homogene-
ity of ovarian follicular inventories among 
cows at the time of induced luteolysis. Im-
proved synchrony of estrus resulting from co-
ordinated follicular maturation and luteal re-
gression (after administering GnRH 7 days 
before PGF2α) was first demonstrated in dairy 
heifers, and later in lactating dairy cattle. 
 
Once a new dominant follicle is selected, 
concentrations of estradiol-17ß increase, LH 
pulses increase, and the selected dominant fol-
licle becomes the preovulatory follicle. 
Maximum concentrations of estradiol-17ß in 
serum preceding ovulation, however, are 30% 
less in lactating dairy cows than in heifers, 
even though ovulatory follicles are 13% larger 
in diameter. Further, maximum concentrations 
of progesterone are 30% less in cows than in 
heifers, despite cows having 53% more luteal 
tissue. Discrepancies between sizes of ovarian 
structures and serum steroid concentrations 
may result from greater rates of steroid me-
tabolism in lactating dairy cows than in heifers 
and among cows of various milk-producing 
abilities. 
 
Reduced serum steroid concentrations may 
have numerous potential physiologic conse-
quences that compromise fertility in lactating 
cows. We hypothesized that greater concentra-
tion of serum estradiol-17ß in lactating cows 
may occur when using the Ovsynch protocol if 
PGF2α-induced luteolysis is delayed after the 
first GnRH injection. Our objective was to 
determine whether lengthening the interval 
between the first GnRH injection and PGF2α 
from 7 to 8 or 9 days might result in greater 
serum concentrations of estradiol-17ß and lar-
ger follicles, possibly leading to increased fer-
tility after AI. 
 
Procedures 
 
 The experiment was conducted at the Kan-
sas State University Dairy Teaching and Re-
search Center, with 36 lactating Holstein cows 
that calved between August and September 
2004 and had an average body condition score 
= 2.3 ± 0.1.  Daily test-day milk yield of these 
cows nearest to the day of first AI averaged 
109 ± 4 lb (3.5% fat and 3.0% protein) and 
305-d mature equivalent yield averaged 
33,854 ± 946 lb. Cows were housed in cov-
ered free stalls bedded with sand, and were fed 
a TMR 3 times daily. 
 
Beginning at 65 ± 2 days postpartum, es-
trous cycles were synchronized in lactating 
dairy cows (average body weight = 1,559 ± 26 
lb) by applying a progesterone-releasing con-
trolled internal drug release (CIDR) insert 
(Eazi-Breed CIDR, Pfizer Animal Health, 
New York, NY) for 7 days, plus 25 mg of 
PGF2α (Lutalyse, Pfizer Animal Health, New 
York, NY) given 24 hr before CIDR insert 
removal.  Nine days after CIDR insert re-
moval (approximately day 6 of the estrous cy-
cle), cows received 100 µg of GnRH (Cystore-
lin, Merial Limited, Iselin, NJ) and then were 
allocated randomly to 1 of 3 treatments in 
which they received 25 mg of PGF2α at days 
7, 8, or 9 after the first GnRH injection (day 0 
was 81 ± 2 days postpartum). 
 
Inseminations were administered at 48 hr 
after PGF2α (91 ± 2 postpartum), at which time 
the second 100-µg injection of GnRH was 
administered.  Pregnancy was diagnosed, 32 
to 34 days after TAI, by using transrectal ul-
trasonography. A positive diagnosis included 
confirmation of a CL, uterine fluid, and an 
embryonic heart beat. 
 
Ultrasonography was conducted on days 0 
and 2, and daily thereafter, beginning with  
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PGF2α treatment and continuing through 72 hr 
after PGF2α, to monitor ovarian structures. 
Ovarian follicles were mapped and sized on 
days 0 and 2 to determine responses to the 
first GnRH injection.  In subsequent scans, all 
follicles were mapped and sized to monitor the 
dominant ovarian follicle that developed after 
the first GnRH injection, and that later became 
the preovulatory follicle. 
 
Blood samples were collected from a coc-
cygeal vessel on days 0 and 2; daily thereafter, 
beginning with PGF2α treatment and continu-
ing through 72 hr after PGF2α; on day 14; and 
on day 21. The samples were stored on ice, 
and serum concentrations of progesterone and 
estradiol-17ß were later quantified by radio-
immunoassay. 
 
Results and Discussion 
 
Changes in average diameter of the largest 
(putative dominant) follicle that subsequently 
ovulated, monitored after the first GnRH in-
jection, are illustrated in Figure 1.  Small dif-
ferences were detected among treatments in 
the diameter of the largest follicle from days 2 
to 10.  Cows in the 9-day treatment had 
slightly smaller (P<0.05) follicle diameters on 
days 2 to 9. Average diameter or average vol-
ume of the resulting preovulatory follicles, 
however, assessed at 72 hr after PGF2α, did 
not differ among treatments (Table 1).  When 
diameters and volumes (not shown) of the 
preovulatory follicles were standardized to the 
day when PGF2α treatment was administered, 
no differences were detected among treat-
ments. At least 1 follicle ovulated per cow 
(range of 1 to 2), and ovulation rates did not 
differ among treatments (Table 1). 
 
When serum concentrations of estradiol-
17ß (not shown) were expressed relative to 
days since PGF2α treatment, no differences 
were evident among treatments. Patterns of 
luteal regression, as assessed by decreasing 
concentrations of progesterone at 24 and 48 hr 
after PGF2α (not shown), were not different 
when expressed relative to day of PGF2α 
treatment injection. All 32 cows subsequently 
ovulated and formed new CL (Table 1) after 
treatment, as is further evidenced by increased 
concentrations of progesterone in serum at 14 
and 21 days after the first GnRH injection (not 
shown). 
 
Two cows each in the 7- and 8-day treat-
ments were inseminated 24 hr late (not ac-
cording to protocol).  Of the remaining cows 
in each of these 2 treatments, 5 of 9 cows 
(55.6%) conceived in the 7-day treatment, and 
5 of 9 cows (55.6%) conceived in the 8-day 
treatment, compared with only 1 of 10 cows 
(10%) in the 9-day treatment.  Conception 
rates of individual 7- and 8-day treatments 
tended (P = 0.07) to differ from that of the 9-
day treatment. Two of the 4 cows (50%) that 
failed to ovulate after the first GnRH injection 
conceived, whereas 9 of 24 cows (37.5%) 
conceived that ovulated at least 1 follicle after 
the first GnRH injection. Although too few 
cows were inseminated to test differences in 
conception rates, reproductive outcomes may 
not be reduced when PGF2α injection is de-
layed by 24 hr from the standard 7-day period 
between GnRH and PGF2α injections, but 48 
hr may be too long to prevent a potentially 
reduced conception rate. 
 
In conclusion, prolonging the lifespan of a 
newly recruited dominant follicle in the pres-
ence of a functional CL by 24 to 48 hr, from 
the standard 7-day interval between the first 
GnRH injection of the Ovsynch protocol and 
the injection of PGF2α, failed to increase se-
rum concentrations of estradiol-17ß or diame-
ter of that dominant follicle. Further study is 
warranted to verify whether delaying PGF2α 
injections by 24 h has no effects on fertility 
and whether PGF2α injections may be given 
late (d 8), when not given at d 7 as planned. 
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Table 1.  Largest Diameter and Volume of Preovulatory Follicles that Ovulated After 
Treatment in Response to the Second GnRH Injection, and Resulting Ovulation Rate 
Interval Between First GnRH 
Injection and PGF2α, days 
Item1 7 8 9 
Diameter of largest follicle, mm 14.3 ± 0.6 14.1± 0.8 15.3± 0.9 
Volume of largest follicle, mm3 1526 ± 62 1479 ± 97 1490 ± 69 
Ovulation rate 1.2 ± 0.1 1.1 ± 0.1 1.3 ± 0.2 
1Assessed 72 hr after PGF2α in each treatment. 
 
 
 
 
Figure 1.  Changes in Average Diameter of the Dominant Follicle that Eventually Ovulated 
After Each of 3 Treatments in Which PGF2α was Administered Either 7 Days (n = 13), 8 
Days (n = 9), or 9 Days (n = 10) After the First GnRH Injection (d 0). 
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